Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015 (2015), Article ID 376576, 13 pages
http://dx.doi.org/10.1155/2015/376576
Research Article

Effects of 5-Amyno-4-(1,3-benzothyazol-2-yn)-1-(3-methoxyphenyl)-1,2-dihydro-3H-pyrrol-3-one Intake on Digestive System in a Rat Model of Colon Cancer

Institute of Biology, Taras Shevchenko National University, 64/13 Volodymyrska Street, Kyiv 01601, Ukraine

Received 29 April 2015; Revised 2 September 2015; Accepted 9 September 2015

Academic Editor: Péter Krajcsi

Copyright © 2015 Halyna M. Kuznietsova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Bray, A. Jemal, N. Grey, J. Ferlay, and D. Forman, “Global cancer transitions according to the Human Development Index (2008–2030): a population-based study,” The Lancet Oncology, vol. 13, no. 8, pp. 790–801, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Driver, L. Djoussé, G. Logroscino, J. M. Gaziano, and T. Kurth, “Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study,” British Medical Journal, vol. 337, Article ID a2467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. P. I. Olyynychenko, Z. P. Bulkyna, and T. I. Synyboroda, Handbook of Tumors Chemotherapy, Zdorovja, Kiev, Ukraine, 2000 (Russian).
  4. A. M. Garin, “Disseminated colorectal cancer chemotherapy, the sequence of cytostatics appointment,” Practical Oncology, vol. 1, pp. 27–30, 2000 (Russian). View at Google Scholar
  5. N. V. Zhukov and S. A. Tjulandin, “Targeted therapy in the treatment of solid tumors: practice contradicts theory,” Biochemistry, vol. 73, no. 5, pp. 605–618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Imyanitov, “General ideas of ​​the targeted therapy,” Oncology Practice, vol. 11, pp. 123–130, 2010. View at Google Scholar
  7. G. Teletaeva, “Prevention and treatment of gastrointestinal complications of drug therapy (nausea and vomiting, mucositis, diarrhea),” Practical Oncology, vol. 10, pp. 158–167, 2009. View at Google Scholar
  8. V. M. Pineiro-Carrero and E. O. Piñeiro, “Liver,” Pediatrics, vol. 113, no. 4, supplement, pp. 1097–1106, 2004. View at Google Scholar
  9. G. Dubinina and V. Yu, Compound of 1,4-Disubstituted 5-Amino-1,2-Dihydropyrol-3-one, Having Anticarcinogenic Activity, Pat UA 22204, Taras Shevchenko National University of Kyiv, Kiev, Ukraine, 2007.
  10. G. G. Dubinina, O. O. Chupryna, M. O. Platonov et al., “In silico design of protein kinase inhibitors: successes and failures,” Anti-Cancer Agents in Medicinal Chemistry, vol. 7, no. 2, pp. 171–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Kaiser, Y.-K. Park, J. L. Franklin et al., “Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer,” Genome Biology, vol. 8, article R131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Uronis, H. H. Herfarth, T. C. Rubinas, A. C. Bissahoyo, K. Hanlon, and D. W. Threadgill, “Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage,” Cancer Research, vol. 67, no. 24, pp. 11594–11600, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Perše and A. Cerar, “Morphological and molecular alterations in 1,2-dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 473964, 14 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Takahashi and K. Wakabayashi, “Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents,” Cancer Science, vol. 95, no. 6, pp. 475–480, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. D. W. Rosenberg, C. Giardina, and T. Tanaka, “Mouse models for the study of colon carcinogenesis,” Carcinogenesis, vol. 30, no. 2, pp. 183–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kanneganti, M. Mino-Kenudson, and E. Mizoguchi, “Animal models of colitis-associated carcinogenesis,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 342637, 23 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Lee, Adverse Drug Reactions, Pharmaceutical Press, London, UK, 2006.
  18. D. L. Shuey, R. W. Setzer, C. Lau et al., “Biological modeling of 5-fluorouracil developmental toxicity,” Toxicology, vol. 102, no. 1-2, pp. 207–213, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Perse and A. Cerar, “The dimethylhydrazine induced colorectal tumours in rat-experimental colorectal carcinogenesis,” Radiology and Oncology, vol. 39, pp. 61–70, 2005. View at Google Scholar
  20. J. Kiernan, Histological and Histochemical Methods: Theory and Practice, Cold Spring Harbor Laboratory Press, New York, NY, USA, 4th edition, 2008.
  21. A. Burlaka and E. Sydoryk, Reactive Oxygen Species and Nitric Oxide in Tumor Process, Naukova Dumka, Kiev, Ukraine, 2006.
  22. T. Obtułowicz, M. Swoboda, E. Speina et al., “Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients,” Mutagenesis, vol. 25, no. 5, pp. 463–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Finkbeiner and R. Davis, Autopsy Pathology: A Manual and Atlas, Churchill Livingstone, New York, NY, USA, 2003.
  24. D. B. Njoku, “Drug-induced hepatotoxicity: metabolic, genetic and immunological basis,” International Journal of Molecular Sciences, vol. 15, no. 4, pp. 6990–7003, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Di Gion, F. Kanefendt, A. Lindauer et al., “Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles,” Clinical Pharmacokinetics, vol. 50, no. 9, pp. 551–603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Afzal, S. A. Jensen, J. B. Sørensen, T. Henriksen, A. Weimann, and H. E. Poulsen, “Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin,” Cancer Chemotherapy and Pharmacology, vol. 69, no. 2, pp. 301–307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Alrawi, M. Schiff, R. E. Carroll et al., “Aberrant crypt foci,” Anticancer Research, vol. 26, no. 1, pp. 107–119, 2006. View at Google Scholar · View at Scopus
  28. V. Khurana, M. Minocha, D. Pal, and A. K. Mitra, “Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors,” Drug Metabolism and Drug Interactions, vol. 29, no. 3, pp. 179–190, 2014. View at Publisher · View at Google Scholar
  29. M. Miura, “Therapeutic drug monitoring of imatinib, nilotinib, and dasatinib for patients with chronic myeloid leukemia,” Biological & Pharmaceutical Bulletin, vol. 38, no. 5, pp. 645–654, 2015. View at Publisher · View at Google Scholar
  30. P.-P. Dong, Z.-Z. Fang, Y.-Y. Zhang et al., “Substrate-dependent modulation of the catalytic activity of CYP3A by erlotinib,” Acta Pharmacologica Sinica, vol. 32, no. 3, pp. 399–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Y.-J. Wang, Y.-K. Zhang, R. J. Kathawala, and Z.-S. Chen, “Repositioning of tyrosine kinase inhibitors as antagonists of ATP-binding cassette transporters in anticancer drug resistance,” Cancers, vol. 6, no. 4, pp. 1925–1952, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. P. E. Jackson, P. J. O'Connor, D. P. Cooper, G. P. Margison, and A. C. Povey, “Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine,” Carcinogenesis, vol. 24, no. 3, pp. 527–533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. W.-M. Wong, N. Mandir, R. A. Goodlad et al., “Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission,” Gut, vol. 50, no. 2, pp. 212–217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. H. K. Roy, W. J. Karolski, and A. Ratashak, “Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone,” International Journal of Cancer, vol. 92, no. 4, pp. 609–615, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Hernandez, J. Sotolongo, K. Breglio et al., “The role of prostaglandin E2 (PGE2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasiaa,” BMC Gastroenterology, vol. 10, article 82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Refaat, A. G. El-Shemi, O. A. Kensara et al., “Vitamin D3 enhances the tumouricidal effects of 5-fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer,” Journal of Experimental & Clinical Cancer Research, vol. 34, no. 1, article 71, 2015. View at Publisher · View at Google Scholar
  37. H. M. Kuznietsova, H. M. Svitina, O. V. Lynchak et al., “The evaluation of new colorectal cancer treatments on chemically induced colon cancer model,” United European Gastroenterology Journal, vol. 2, no. 1, supplement, p. A237, 2014. View at Google Scholar
  38. J. Nautiyal, S. S. Kanwar, and A. P. N. Majumdar, “EGFR(s) in aging and carcinogenesis of the gastrointestinal tract,” Current Protein and Peptide Science, vol. 11, no. 6, pp. 436–450, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Maurer, T. Su, L. H. Saal et al., “PDK1 potentiates upstream lesions on the PI3K pathway in breast carcinoma,” Cancer Research, vol. 69, no. 15, pp. 6299–6306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Lieu and S. Kopetz, “The Src family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy,” Clinical Colorectal Cancer, vol. 9, no. 2, pp. 89–94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Xu, R. R. Steere, C. A. Fedorchuk et al., “Activation of epidermal growth factor receptor is required for NTHi-induced NF-κB-dependent inflammation,” PLoS ONE, vol. 6, no. 11, Article ID e28216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Kuznietsova, T. Volovnenko, G. Ostrovska, V. Yu, and V. Rybalchenko, “The influence of cytostatic compound dihydropyrrol derivative on rat bowel tunica mucosa under oxidative stress condition,” Reports of the NASU, vol. 2, pp. 174–179, 2012. View at Google Scholar
  43. C.-T. Chang, T.-Y. Ho, H. Lin et al., “5-fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging,” PLoS ONE, vol. 7, no. 3, Article ID e31808, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Aota, M. Azuma, T. Yamashita et al., “5-Fluorouracil induces apoptosis through the suppression of NF-κB activity in human salivary gland cancer cells,” Biochemical and Biophysical Research Communications, vol. 273, no. 3, pp. 1168–1174, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. C. S. Lee, E. J. Ryan, and G. A. Doherty, “Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation,” World Journal of Gastroenterology, vol. 20, no. 14, pp. 3751–3761, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. D. B. Longley, D. P. Harkin, and P. G. Johnston, “5-Fluorouracil: mechanisms of action and clinical strategies,” Nature Reviews Cancer, vol. 3, no. 5, pp. 330–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Fu, G. Yang, F. Zhu et al., “Antioxidants decrease the apoptotic effect of 5-Fu in colon cancer by regulating Src-dependent caspase-7 phosphorylation,” Cell Death & Disease, vol. 5, no. 1, article e983, 2014. View at Publisher · View at Google Scholar
  48. I. Kharchuk, O. Andrukhov, G. Ostrovska, and V. Rybalchenko, “Maleimide and dihydropyrrol derivatives as potential antiproliferative and apoptosis-inducing compounds,” Reports of the NASU, vol. 12, pp. 149–156, 2012. View at Google Scholar